Navidea Biopharma (NAVB) Reports Q4 Loss of $0.03

March 8, 2018 4:27 PM

Navidea Biopharma (NYSE: NAVB) reported Q4 EPS of ($0.03), versus ($0.02) reported last year. Revenue for the quarter came in at $395 thousand, versus $1 million reported last year.

For earnings history and earnings-related data on Navidea Biopharma (NAVB) click here.

Categories

Earnings Guidance